Brain Injuries, Traumatic

The immediate cause is sudden trauma to the head or brain. The supplied grounding does not support a more specific aetiology beyond traumatic injury itself.

Primary trauma triggers cellular damage and the release of damage-associated molecular patterns, which activate resident CNS cells and recruit peripheral immune cells. Secondary injury processes include neuroinflammation, oxidative stress, vasogenic and cytotoxic oedema, hypoxia-ischaemia, apoptosis, cellular hyperexcitability, and chronic tissue degeneration. Astrocytes and microglia are key mediators of the inflammatory response, while changes in mitochondrial dynamics, neuronal plasticity, and brain-gut axis signaling are also implicated.

The supplied grounding does not identify specific pre-injury risk factors. It does indicate that military-related mild traumatic brain injury is a notable context of occurrence, but not a general risk factor for the disease itself.

The supplied grounding supports treatment at the level of broad modalities rather than specific regimens. Management includes therapy and drug therapy aimed at limiting secondary injury and addressing complications, with attention to neuroinflammation, recovery, and associated neurological or psychological sequelae. The literature also discusses biomarker-guided and mechanism-based approaches, but does not provide a single standard drug class or definitive curative treatment.